Image: EFF (CC-BY)
Dear Mr. President: The organizations signing this letter want to express our deep concerns regarding some of the provisions under negotiation in the Trans Pacific Partnership (TPP). These provisions could seriously impact access to affordable medicines by delaying generic competition as well as impacting governments’ ability to advance public health policies in the U.S and around the world.
While we have different perspectives and interests, we are united by our shared concerns regarding access to affordable medicines and the need to ensure competition in the pharmaceutical market in the U.S. and abroad.
